Table 1.
Nrf2 promotes monocyte and macrophage tissue invasion in a broad range of disease states
Although the function of Nrf2 is most commonly described as anti-inflammatory, Nrf2 actively promotes inflammation and monocyte and macrophage invasion into damaged epithelial tissues across a range of mouse disease models, and in multiple tissue types.
Disease Model | Experimental System | NRF2 phenotype | Reference |
---|---|---|---|
Steatohepatitis | Hepatocyte-specific NEMO CKO mouse | Keap1 DKO mice exhibit increased monocyte-derived | [53] |
macrophages in the diseased livers | |||
DSS-induced colitis | Adipocyte-specific Atg7 CKO mouse | Nrf2 activation by the non-canonical p62 pathway resulted | [54] |
in increased monocyte invasion into the damage colons | |||
Pancreatitis | Pancreatic acinar-specific VMP1 CKO mouse | Nrf2 DKO mice exhibit decreased inflammation and | [55] |
macrophage infiltration into the damaged pancreases | |||
Autoimmune nephritis | Fas mutant lpr/lpr mice | Nrf2 DKO mice exhibit decreased macrophage, CD4 | [56] |
and CD8 T cell infiltration into the damaged kidneys | |||
Lung cancer | scRNA-Seq analysis of human lung tumours | KEAP1 mutant tumours are enriched with proinflammatory | [57] |
monocyte-derived macrophages (CP2E pattern) |